FDA Recognizes Salt As Generally ‘Safe’; Advocacy Group Wants That Status Removed
In other public health news, researchers find that intense early intervention can lead to recovery for people diagnosed with schizophrenia.
The independent source for health policy research, polling, and news.
39,801 - 39,820 of 112,485 Results
In other public health news, researchers find that intense early intervention can lead to recovery for people diagnosed with schizophrenia.
Also in California, Gov. Jerry Brown signs three bills aimed at limiting prescriptions of antipsychotics for foster children. Meanwhile, the Food and Drug Administration faces criticism for its continued approval of OxyContin for kids. And the growing heroin epidemic puts more minors into the state foster systems.
One Wall Street analyst says there's no middle ground forward for investment in biotech firms, whose products are becoming the focus of scrutiny after big price hikes. Elsewhere, a new multiple sclerosis drug from Roche shows promise, and there's news on a takeover bid by Blackstone and an impending sale by Clayton, Dubilier & Rice of a drug-compounding firm.
Negotiators struck a compromise on the major issue of patent protections for biologics and vaccines that left no party completely happy.
Arizona has already expanded its Medicaid program, but lawmakers there want to set tougher standards for those who are eligible. News outlets also report on the wait in Montana for the federal government to consider the state's expansion plans and a controversial statement by an aide to the Kansas governor.
House Republicans will meet Friday morning to discuss next steps in electing a leader following Rep. Kevin McCarthy's surprise withdrawal from the race Thursday. Rep. Paul Ryan has resisted recruitment appeals so far.
Chairman of the House Oversight and Government Reform Committee Jason Chaffetz (R-Utah) says his committee's hearings have not found that the reproductive health organization is improperly handling its finances. He says investigations may continue. At a hearing yesterday, a former employee said that Planned Parenthood did bill Medicaid for abortion services. The woman made similar claims in a lawsuit that in 2014 an Iowa appeals court said did not have enough evidence to go forward.
With a revolution in U.S. health care -- in both how care is delivered and paid for -- schools that train doctors are scrambling to revamp. Also, a Michigan paper examines the burden on nurses at an understaffed state hospital, and a study analyzes patient attitudes about being discharged from the hospital.
The legislation, introduced in the Senate, would close a loophole in the law that requires public disclosure of such payments to doctors and some other health providers.
Insurers who hoped to get billions in aid after opening-year losses from their participation in the health law's insurance marketplaces are only getting 12.6 percent of what they requested after the fund to pay them fell short. In the meantime, Obamacare dropouts get picked up by employer coverage in California, and Wyoming loses one of its two health law insurers.
Almost three out of four beneficiaries are enrolled in medical and drug coverage plans that received at least a four-star quality rating, according to the Centers for Medicare and Medicaid Services. The rankings did show a drop for some companies, especially in regard to prescription drug benefits.
Meanwhile, news outlets report on other cancer care developments like the impact of life-expectancy questions on patients and what elephant genes could teach researchers about fighting the disease.
Today’s early morning highlights from the major news organizations.
A selection of opinions on health care from around the country.
Each week, KHN's Shefali Luthra finds interesting reads from around the Web.
News outlets report on health care issues in California, Iowa, Massachusetts and New Jersey.
The New York Times examines efforts by some experts to move focus to early detection and preventive measures to keep help prevent gun violence. In other reports on public health issues, KHN talks to an expert about avoiding diagnostic errors, and NBC looks at the spiraling cost of specialty drugs.
Robert McDonald says that progress has already been made on many of the issues cited in the $68-million independent audit and that the Department of Veterans Affairs needs a bigger budget to go further. Meanwhile, a groundbreaking program in Milwaukee, Wis., has veterans act out battle-heavy scenes in Shakespeare plays to help them process their emotions.
The Office of Special Counsel says the complaints were not substantiated. In other Food & Drug Administration news, Dr. Robert Califf, the Duke cardiologist nominated to lead the agency, asked to have his name removed from a series of papers examining clinical trials that he co-wrote. The unusual move raised questions and potential ethical concerns.
Those decisions could help provide some break to the breathtaking increases in drug prices consumers have seen in recent years. Also in marketplace news, Walmart prepares for a massive, nationwide health fair, and PharMerica agrees to settle allegations that it received kickbacks for promoting a drug.
© 2026 KFF